SGLT2 Inhibitors (e.g., Dapagliflozin)
Treatment used for 2 conditions
Total Trials
55
Total Participants
75K
Avg Effectiveness
94%
Avg Safety Score
65%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.